Moderna shares surge after vaccine maker posts unexpected third …

Moderna Shares Surge After Vaccine Maker Posts Unexpected Third …

2 weeks from now

Moderna also unveiled net profit of $13 million, or $0.03 a share, compared to a loss of $3.6 billion a year ago and above expectations for a loss of $753 million, according to LSEG data cited by ...

msn.com

Moderna Reports Third Quarter 2024 Financial Results And …

2 weeks from now

Nov 7, 2024  · Additionally, the Company commenced sales of its RSV vaccine during the third quarter of 2024. RSV vaccine sales were $10 million in the quarter. ... as amended, including …

modernatx.com

Moderna Reports Surprise Profit On Higher-Than-Expected COVID …

2 weeks from now

Nov 7, 2024  · U.S. market share for Spikevax was 40%, down from 45% in the third quarter of 2023, Moderna said. Mock said around 7.5 million patients had received Spikevax this year.

usnews.com

Moderna Surges 14% After Covid Vaccine-Maker Surprises With …

2 weeks from now

Feb 22, 2024  · Moderna stock surged Thursday after the Covid vaccine-maker beat Wall Street's quarterly expectations, including turning around a surprise profit. ↑ X Biotech Stocks Are …

investors.com

Moderna Slashes Hefty Gains With A Beat That's 'Not A Beat'

2 weeks from now

Nov 7, 2024  · Unexpected Profit. Moderna unexpectedly earned 3 cents per share, on a strict, as-reported basis. That flipped from a year-earlier loss of $9.53 per share. Analysts called for a …

investors.com

Moderna's Stock Surges After Better-than-expected Quarterly Results

2 weeks from now

May 2, 2024  · The COVID vaccine maker reported a first-quarter net loss of $1.175 billion, or $3.07 a share, after net income of $79 million, or 19 cents a share, in the year-earlier period. …

morningstar.com

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024  · Vaccine maker looks to enter RSV market in 2024 Moderna Inc. shares (MRNA) jumped more than 7% premarket on Thursday after the company reported a surprise fourth …

morningstar.com

Moderna's MRNA Technology Looks Undervalued Despite Lower …

2 weeks from now

1 day ago  · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …

morningstar.com

Moderna Crashes 21%. 'No Inflection In Sight' After Guidance

2 weeks from now

2 days ago  · Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 …

yahoo.com